Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dry skin, Pruritus, SARS-CoV-2 test
Clinical narrative: after receiving the first Moderna COVID-19 injection she felt odd afterwards but otherwise mentioned it was an uneventful experience; diagnosed with COVID-19 sometime after the first Moderna vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (diagnosed with COVID-19 sometime after the first Moderna vaccination) and FEELING ABNORMAL (after receiving the first Moderna COVID-19 injection she felt odd afterwards but otherwise mentioned it was an uneventful experience) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy, Asthma (Patient reported that it started many years ago. Recent change in status was reported as worsening), Heart disease, unspecified (The patient was a heart patient. Start date was prior to receiving Moderna vaccines. Recent change in status was reported as no change.) and Diabetic (Start date was prior to receiving Moderna vaccines. Recent change in status was reported as no change.).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 01-Apr-2021, the patient experienced FEELING ABNORMAL (after receiving the first Moderna COVID-19 injection she felt odd afterwards but otherwise mentioned it was an uneventful experience). In April 2021, the patient experienced COVID-19 (diagnosed with COVID-19 sometime after the first Moderna vaccination). At the time of the report, COVID-19 (diagnosed with COVID-19 sometime after the first Moderna vaccination) and FEELING ABNORMAL (after receiving the first Moderna COVID-19 injection she felt odd afterwards but otherwise mentioned it was an uneventful experience) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, SARS-CoV-2 test: positive (Positive) Positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient did not receive any other vaccines which was given within 1 month prior to Moderna COVID-19 vaccine.  Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  Company comment: This spontaneous case concerns a 63-year-old female patient with no relevant medical history, who experienced the unexpected, non-serious ADR of COVID 19 which occurred unknown days after receiving first dose of mRNA-1273 vaccine. Further details regarding clinical course, investigations, treatment, and outcome are not available. It was reported that patient was diagnosed with COVID 19 after the second dose also (linked case MOD-2022-548561). The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2022-548561, MOD-2022-548565 (Patient Link).   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a 63-year-old female patient with no relevant medical history, who experienced the unexpected, non-serious ADR of COVID 19 which occurred unknown days after receiving first dose of mRNA-1273 vaccine. Further details regarding clinical course, investigations, treatment, and outcome are not available. It was reported that patient was diagnosed with COVID 19 after the second dose also (linked case MOD-2022-548561). The benefit-risk relationship of mRNA-1273 is not affected by this report.